ImmunoPrecise Antibodies Stock Quote IPA - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.50

Bid

6.31

Ask

6.75

Volume

0.00 Day's Range 0.00

6.50 52 Week Range 6.50

Market Cap

175.136M

Previous Close

6.50

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

26,944,000

Dividend Yield

PE Ratio

-0.54

Earnings Per Share (EPS)

-1.01

Revenue

24.52M

Net Profit

-27.18M

Sector

Pharmaceutical Preparations

Industry

Miscellaneous Metal Ores,nec

Website

www.immunoprecise.com

Headquarters

Victoria, British Columbia, Can

Founded

2016

ImmunoPrecise Antibodies Ltd is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker IPA. The last closing price for ImmunoPrecise Antibodies was $6.50. Over the last year, ImmunoPrecise Antibodies shares have traded in a share price range of $ 6.50 to $ 6.50.

ImmunoPrecise Antibodies currently has 26,944,000 shares outstanding. The market capitalization of ImmunoPrecise Antibodies is $175.14 million. ImmunoPrecise Antibodies has a price to earnings ratio (PE ratio) of -0.54.

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA's Subsidiary BioStrand Secures Second VLAIO Research GrantIPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTs™ with 3D protein structure and...

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and...

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence New Platform...

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of...

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 In vivo, IND enabling evaluations of PolyTope® TATX-03 in animal model show:There were no...

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

Traitement potentiel de la maladie de Parkinson et d'autres affections neurodégénératives IMMUNOPRECISE ANTIBODIES LTD. (la "Société" ou "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) un chef de file...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease Potential to Treat Parkinson's and Other...

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

Potential to Treat Parkinson’s and Other Neurodegenerative Diseases IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic...

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

L'anticorps bloque l'interaction de liaison DFR/ACE2 par le biais d'un mécanisme d'action alternatif L'anticorps se lie à tous les variants préoccupants testés, probablement parce qu'il cible un...

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

Blocks the RBD/ACE2 binding interaction indirectly through an alternative mechanism of action Binds to all tested variants of concern, likely because it targets a site other than the mutation...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	6.5	6.5	6.5	0	0	CS
4	0	0	6.5	6.5	6.5	0	0	CS
12	0	0	6.5	6.5	6.5	0	0	CS
26	0	0	6.5	6.5	6.5	0	0	CS
52	0	0	6.5	6.5	6.5	0	0	CS
156	-1.14	-14.9214659686	7.64	8.44	4.52	5933	6.34183901	CS
260	5.96	1103.7037037	0.54	26.25	0.51	72762	4.07959812	CS

IPA - Frequently Asked Questions (FAQ)

What is the current ImmunoPrecise Antibodies share price?

The current share price of ImmunoPrecise Antibodies is $ 6.50

How many ImmunoPrecise Antibodies shares are in issue?

ImmunoPrecise Antibodies has 26,944,000 shares in issue

What is the market cap of ImmunoPrecise Antibodies?

The market capitalisation of ImmunoPrecise Antibodies is CAD 175.14M

What is the 1 year trading range for ImmunoPrecise Antibodies share price?

ImmunoPrecise Antibodies has traded in the range of $ 6.50 to $ 6.50 during the past year

What is the PE ratio of ImmunoPrecise Antibodies?

The price to earnings ratio of ImmunoPrecise Antibodies is -0.54

What is the cash to sales ratio of ImmunoPrecise Antibodies?

The cash to sales ratio of ImmunoPrecise Antibodies is 0.59

What is the reporting currency for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies reports financial results in CAD

What is the latest annual turnover for ImmunoPrecise Antibodies?

The latest annual turnover of ImmunoPrecise Antibodies is CAD 24.52M

What is the latest annual profit for ImmunoPrecise Antibodies?

The latest annual profit of ImmunoPrecise Antibodies is CAD -27.18M

What is the registered address of ImmunoPrecise Antibodies?

The registered address for ImmunoPrecise Antibodies is 3204 - 4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8

What is the ImmunoPrecise Antibodies website address?

The website address for ImmunoPrecise Antibodies is www.immunoprecise.com

Which industry sector does ImmunoPrecise Antibodies operate in?

ImmunoPrecise Antibodies operates in the MISCELLANEOUS METAL ORES,NEC sector

Symbol	Price	Vol.
FINV.PFaction Investment Group Corp	$ 0.05 (233.33%)	17k
ADG.HArcus Development Group Inc	$ 0.015 (200.00%)	10k
AZC.PA2ZCryptocap Inc	$ 0.095 (171.43%)	1.01k
CBAChampion Bear Resources Ltd	$ 0.035 (133.33%)	9k
XBOTRealbotix Corp	$ 0.56 (124.00%)	7.15M
MSPMinaean SP Construction Corp	$ 0.005 (-66.67%)	7k
MUST.HMust Capital Inc	$ 0.025 (-58.33%)	215k
CART.HCarcetti Capital Corp	$ 0.13 (-51.85%)	4.5k
NICKNickelex Resource Corporation	$ 0.005 (-50.00%)	300k
IDIdentillect Technologies Corp	$ 0.005 (-50.00%)	425k
GPUSAlset AI Ventures Inc	$ 0.21 (31.25%)	10.69M
MATEBlockmate Ventures Inc	$ 0.375 (-8.54%)	7.24M
XBOTRealbotix Corp	$ 0.56 (124.00%)	7.15M
QNCQuantum Emotion Corp	$ 1.76 (21.38%)	6.09M
AECAnfield Energy Inc	$ 0.095 (5.56%)	3.84M

Symbol

Price

Vol.